ICC recommends that cases previously reported as TdT-positive BL should be separated from BL and diagnosed as B-ALL/LBL with MYC rearrangement rather than BL as these neoplasms show immunophenotypic and molecular features of precursors B-cells [2,59]. This evidence concerns the gene DNTT and Burkitt lymphoma.